BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16823686)

  • 41. Clinical diagnosis of dementia, not presence of behavioral and psychological symptoms, is associated with psychotropic use in community-dwelling elders classified as having dementia.
    Chan DC; Kasper JD; Black BS; Rabins PV
    J Geriatr Psychiatry Neurol; 2007 Mar; 20(1):50-7. PubMed ID: 17341771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of behavioral abnormalities in patients with dementia].
    Wolf H; Gertz HJ
    MMW Fortschr Med; 2004 Jun; 146(24):43-5. PubMed ID: 15366492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
    Edell WS; Tunis SL
    Am J Geriatr Psychiatry; 2001; 9(3):289-97. PubMed ID: 11481138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What happened to patients with behavioural and psychological symptoms of dementia (BPSD) after the Committee on Safety in Medicines (CSM) guidelines?
    Raju J; Sikdar S; Krishna T
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):898-9. PubMed ID: 16116573
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment.
    Borroni B; Agosti C; Padovani A
    Arch Gerontol Geriatr; 2008; 46(1):101-6. PubMed ID: 17467082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.
    Lanctôt KL; Best TS; Mittmann N; Liu BA; Oh PI; Einarson TR; Naranjo CA
    J Clin Psychiatry; 1998 Oct; 59(10):550-61; quiz 562-3. PubMed ID: 9818639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.
    Champoux N; Monette J; Monette M; Galbaud du Fort G; Wolfson C; Le Cruguel JP
    Can Fam Physician; 2005 May; 51(5):696-7. PubMed ID: 16926926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia.
    Hurt C; Bhattacharyya S; Burns A; Camus V; Liperoti R; Marriott A; Nobili F; Robert P; Tsolaki M; Vellas B; Verhey F; Byrne EJ
    Dement Geriatr Cogn Disord; 2008; 26(2):138-46. PubMed ID: 18679028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Behavioral and psychological symptoms of dementia in a pilot psychogeriatric unit: management and outcomes].
    Koskas P; Belqadi S; Mazouzi S; Daraux J; Drunat O
    Rev Neurol (Paris); 2011 Mar; 167(3):254-9. PubMed ID: 20947112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].
    Gillabert C; Desmeules J; Vogt-Ferrier N; Dayer P
    Rev Med Suisse; 2006 Apr; 2(61):970-5. PubMed ID: 16686329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral and psychological symptoms of dementia: how long does every behavior last, and are particular behaviors associated with PRN antipsychotic agent use?
    Voyer P; McCusker J; Cole MG; Monette J; Champoux N; Ciampi A; Belzile E; Richard H
    J Gerontol Nurs; 2015 Jan; 41(1):22-37; quiz 38-9. PubMed ID: 25369585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.
    Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA
    BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
    Bullock R
    Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
    Ballard C; Lana MM; Theodoulou M; Douglas S; McShane R; Jacoby R; Kossakowski K; Yu LM; Juszczak E;
    PLoS Med; 2008 Apr; 5(4):e76. PubMed ID: 18384230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioural and psychological signs and symptoms of dementia across cultures: current status and the future.
    Shah A; Dalvi M; Thompson T
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1187-95. PubMed ID: 16315147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Psychological and behavioural symptoms of dementia: prevention, diagnosis and treatment].
    Olazaran-Rodriguez J; Aguera-Ortiz LF; Muniz-Schwochert R
    Rev Neurol; 2012 Nov; 55(10):598-608. PubMed ID: 23143961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia.
    Wancata J
    Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing antipsychotic effectiveness in dementia: a factor analysis approach.
    Espinoza R
    J Am Med Dir Assoc; 2003; 4(2):113-4. PubMed ID: 12807586
    [No Abstract]   [Full Text] [Related]  

  • 60. A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD).
    Greve M; O'Connor D
    Int Psychogeriatr; 2005 Jun; 17(2):195-205. PubMed ID: 16050430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.